The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. Experts think the new strike force ...

GoodRx, a prescription savings platform, introduced GoodRx Employer Direct on Tuesday, an offering that allows employers to lower the cost of certain brand medications like GLP-1s. Santa Monica, ...

When a biotech startup reveals a substantial round of funding, the announcement typically includes information about a pipeline, or at least a lead drug candidate. Large sums are also often a sign of ...

The high cost of GLP-1s is causing some employers to reconsider their coverage, a new survey from the Business Group on Health found. The survey received responses from 105 self-funded employers. It ...

Capstan’s initial focus is the development of in vivo chimeric antigen receptor, or CAR T, therapies. CAR T-drugs are currently made from a patient’s own T cells, which are engineered in a lab before ...

Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California ...

Critical care transport is one of the most intense and demanding parts of emergency medical services. We’re talking about patients in the most fragile situations: premature newborns, trauma victims, ...

Texas Attorney General Ken Paxton sued Epic this week, alleging that the company is monopolizing the EHR market and restricting patients’ access to their own medical data. Epic’s EHR systems are ...

AbbVie is joining the chase for new obesity drugs, but rather than getting a me-too GLP-1 drug, the pharmaceutical giant is landing rights to a clinical-stage molecule that goes after two novel ...

Invitae’s business operations are heading to a new home. Under a bankruptcy auction, Labcorp was selected as the winning bidder for the firm’s genetic testing services, digital health solutions, and ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S.

It’s 2 a.m. A mother calls into a nurse triage line. Her baby isn’t screaming. She’s not rattling off symptoms. She just keeps saying, “something’s wrong.” And the nurse on the other end of that phone ...